To Study the application of ATP based bioluminescence tumor chemosensitivity assay (ATP -tca) in the chemotherapy of breast cancer.
目的探讨AT P生物荧光肿瘤药敏检测技术(atp -TCA)在乳腺癌化疗中的应用价值。
Objective To Study the clinical value and application of ATP based Bioluminescence Tumor Chemosensitivity Assay (ATP-TCA) in the chemotherapy of breast cancer.
目的探讨AT P生物荧光肿瘤药敏检测技术(atp TCA)在乳腺癌化疗中的临床意义及应用价值。
A great progress has been achieved in the chemotherapy of breast cancer. It includes the invention of new drugs, the improvement of strategy for chemotherapy and so on.
近年来乳腺癌在化疗方面有较大进展，包括新化疗药物的陆续开发问世，化疗策略的不断完善和革新等。
Rosen says tests using laboratory mice suggest the heat treatments may be an effective way of augmenting radiation or chemotherapy for patients with some kinds of tumors, including breast cancer.
Rosen表示，在实验用小鼠的实验中，对于某些类型的肿瘤，例如乳腺癌，热疗法是提高辐射疗法和化学疗法威力的有效方法。
With this in mind, Jeffrey Rosen and his colleagues at Baylor College of Medicine in Houston, Texas, compared samples from breast-cancer patients taken before and after 12 weeks of chemotherapy.
针对这个问题，位于坦萨斯州休斯敦拜尔医学院的JeffreyRosen博士与他的同事一起，对乳腺癌患者的样本进行了比较——进行化疗12周后及化疗前的。
For women who have had surgery for early breast cancer, it may not matter whether they receive follow-up chemotherapy before, after or during radiation therapy, according to a new review of studies.
根据一项新的研究综述，对于已经实施早期乳腺癌癌手术的妇女来说，她们不论在放疗之前、放疗中还是之后接受后续的化疗都不要紧。
Chemotherapy is given to women with early breast cancer, after surgery and radiotherapy to mop up any molecules of the cancer that may have spread round the body to other organs.
在手术和放疗后，对早期乳腺癌患者进行化疗可以清除可能扩散到机体其他器官的一些癌分子。
Objective: To evaluate the effect of neoadjuvant chemotherapy in the treatment of locally advanced breast cancer.
前言： 目的：探讨新辅助化疗在局部晚期乳腺癌治疗中的应用。
The study compared a combination of chemotherapy drugs - the standard treatment - to a single drug in patients with early-stage breast cancer aged 65 and older.
本研究比较了一种联合化疗药物(标准治疗方法)与单一药物对65岁及以上老年早期乳腺癌患者的疗效。
Women with breast cancer who receive drugs known as taxanes after standard chemotherapy have a substantially reduced risk of recurrence and of death.
患乳腺癌的妇女接受有名的紫杉烷类药物的标准化疗后能实质性的降低复发和死亡的危险。
Thousands of breast cancer patients each year could be spared chemotherapy or get gentler versions of it without harming their odds of beating the disease, new research suggests.
一个新的研究表明，每年数以千计的乳腺癌患者可以减少（避免）化疗或采用更温和的化疗，而不会降低治疗的效果。
Objective To study the clinical effect of neoadjuvant chemotherapy on advanced breast cancer.
目的探讨新辅助化疗在晚期乳腺癌治疗中的效果。
Unlike the hormonal treatment Herceptin, which is effective in only 20 per cent of patients with oestrogen-positive breast cancer, chemotherapy works for all women.
与赫赛汀激素疗法不同的是，赫赛汀激素疗法仅对20%雌激素阳性的乳腺癌患者有效，而该化疗是针对所有乳腺癌妇女的。
Objective To evaluate therapeutic effect and adverse effect of ibandronate combined with chemotherapy in breast cancer patients with bone metastases.
目的观察伊班膦酸钠(艾本)联合化疗对乳腺癌骨转移的止痛效果和不良反应。
Purpose: To analyze and study the characteristics of diagnosis, multidisciplinary treatment including surgery, chemotherapy and radiotherapy of pregnancy-associated breast cancer.
目的：研究妊娠期乳腺癌在诊断和手术、化疗、放疗综合治疗方面的特殊性。
CONCLUSION Physical and psychosocial functioning improved significantly after breast cancer treatment, independent of receipt of adjuvant chemotherapy.
结论：乳腺癌辅助化疗后生理和心理功能明显改善，不受辅助化疗方案的影响。
The optimal sequencing of adjuvant chemotherapy (CT) and radiation therapy (RT) in patients with early-stage breast cancer remains unclear.
辅助放疗和化疗在早期乳腺癌的最佳顺序至今仍没有结论。
Objective:To investigate the heterogeneity of chemosensitivity in breast cancer using an ATP-tumor chemosensitivity assay (ATP-TCA) and the feasibility of individual chemotherapy.
目的：探讨用ATP生物荧光肿瘤体外药敏检测技术（ATP-TCA）研究乳腺癌药物敏感性的异质性以及个体化治疗的可行性。
Purpose to evaluate whether diabetes affects patterns of adjuvant chemotherapy use, toxic effects of chemotherapy, and breast cancer outcomes.
目的：评估糖尿病是否影响化疗模式使用、化疗毒性反应和乳腺癌治疗效果。
Doctors may also prescribe chemotherapy to women at high risk for having the cancer spread to other parts of the body after surgery, to reduce the risk of dying from breast cancer.
医生也可以对手术后癌症转移的处于高度危险的妇女开化疗处方，来降低乳腺癌的死亡率。
Objective: To study adverse drug reactions (ADRs) of adjuvant chemotherapy and hormonal treatment of patients with breast cancer.
目的：了解乳腺癌辅助化疗及激素治疗的药物不良反应。
Objective To study the correlation of breast cancer stem cell with relapse of breast cancer after chemotherapy.
目的探讨乳腺癌干细胞与乳腺癌化疗失败的相关性。
Conclusion:The overexperssion of VEGF may be predict poor prognosis and VEGF examined is helpful for chemotherapy plan of breast cancer.
结论：VEGF过表达提示患者预后不良，检测VEGF对化疗方案选择有指导意义。
Objective: To evaluate the significance of neoadjuvant chemotherapy in elder breast cancer patients.
目的：探讨新辅助化疗在老年乳腺癌患者治疗中的意义。
Objective To appraise the effect of preoperative catheterization chemotherapy in the treatment of breast cancer.
目的评价术前动脉灌注化疗在乳腺癌治疗中的作用。
Objective To explore the relationship of chemotherapy sensitivity and expression of multidrug resistance genes and apoptosis regulation genes in human breast cancer cell lines.
目的探讨人乳腺癌细胞化疗敏感性与多药耐药相关基因和凋亡调控基因表达的关系。
Objective to investigate the effect of preoperative regional intra-arterial chemotherapy on apoptosis and apoptosis-regulating genes in advanced breast cancer.
目的探讨术前区域性动脉灌注化疗对晚期乳腺癌细胞凋亡及其相关基因表达的影响。
Objective To explore paclitaxel(PTX) union chemotherapy curative effect and security for breast cancer of later period.
目的探讨紫杉醇（PTX）为主的联合化疗方案治疗晚期乳腺癌的疗效及安全性。
Objective To explore paclitaxel(PTX) union chemotherapy curative effect and security for breast cancer of later period.
目的探讨紫杉醇（PTX）为主的联合化疗方案治疗晚期乳腺癌的疗效及安全性。
应用推荐